title: BAG3 facilitates the clearance of endogenous tau in primary neurons.
abstract: Tau is a microtubule associated protein that is found primarily in neurons, and in pathologic conditions, such as Alzheimer's disease (AD) it accumulates and contributes to the disease process. Because tau plays a fundamental role in the pathogenesis of AD and other tauopathies, and in AD mouse models reducing tau levels improves outcomes, approaches that facilitate tau clearance are being considered as therapeutic strategies. However, fundamental to the development of such interventions is a clearer understanding of the mechanisms that regulate tau clearance. Here, we report a novel mechanism of tau degradation mediated by the co-chaperone BAG3. BAG3 has been shown to be an essential component of a complex that targets substrates to the autophagy pathway for degradation. In rat primary neurons, activation of autophagy by inhibition of proteasome activity or treatment with trehalose resulted in significant decreases in tau and phospho-tau levels. These treatments also induced an upregulation of BAG3. Proteasome inhibition activated JNK, which was responsible for the upregulation of BAG3 and increased tau clearance. Inhibiting JNK or knocking down BAG3 blocked the proteasome inhibition-induced decreases in tau. Further, BAG3 overexpression alone resulted in significant decreases in tau and phospho-tau levels in neurons. These results indicate that BAG3 plays a critical role in regulating the levels of tau in neurons, and interventions that increase BAG3 levels could provide a therapeutic approach in the treatment of AD.
authors.affiliation: Department of Anesthesiology, University of Rochester Medical Center, University of Rochester, Rochester, NY, USA.
authors.forename: Zhinian
authors.initials: Z
authors.lastname: Lei
authors.affiliation: Department of Anesthesiology, University of Rochester Medical Center, University of Rochester, Rochester, NY, USA.
authors.forename: Corey
authors.initials: C
authors.lastname: Brizzee
authors.affiliation: Department of Anesthesiology, University of Rochester Medical Center, University of Rochester, Rochester, NY, USA. Electronic address: gail_johnsonvoll@urmc.rochester.edu.
authors.forename: Gail V W
authors.initials: GV
authors.lastname: Johnson
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism / Q000502:physiology*; D000544:Alzheimer Disease / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000378:metabolism / Q000502:physiology*; D001343:Autophagy / Q000235:genetics; D002478:Cells, Cultured; D058990:Molecular Targeted Therapy; D009474:Neurons / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex; D059748:Proteolysis; D051381:Rats; D014199:Trehalose / Q000494:pharmacology; D015854:Up-Regulation / Q000187:drug effects; D016875:tau Proteins / Q000378:metabolism* / Q000502:physiology
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; C498807:BAG3 protein, rat; D016875:tau Proteins; D014199:Trehalose; D046988:Proteasome Endopeptidase Complex
keywords: Alzheimer's disease; Autophagy; BAG3; Co-chaperone; JNK; Tau